{"id":7079,"date":"2021-02-19T11:33:00","date_gmt":"2021-02-19T08:33:00","guid":{"rendered":"https:\/\/roboforex.com\/blog\/?p=7079"},"modified":"2023-06-23T09:06:18","modified_gmt":"2023-06-23T06:06:18","slug":"tilray-stocks-leaping-up-and-falling-down","status":"publish","type":"post","link":"https:\/\/roboforex.com\/blog\/2021\/02\/19\/tilray-stocks-leaping-up-and-falling-down\/","title":{"rendered":"Tilray Stocks: Leaping Up and Falling Down"},"content":{"rendered":"\n

A week ago, we told you about the swift growth of such cannabis companies<\/a> as  Canopy Growth, Tilray, OrganiGram Holdings, Aphria, Aurora Cannabis, and HEXO. To go on with the topic, today we’ll give you more details about one of them called Tilray.<\/p>\n\n\n\n

<\/span>What’s going on with Tilray stocks?<\/span><\/h2>\n\n\n\n

On Wednesday, December 16th, the stock price of a Canadian company, registered in the USA and called Tilray (NASDAQ: TLRY) grew by 19.41% to 34.63 USD each. The growth was provoked by the most interesting news: Bloomberg revealed that Tilray and Aphria had agreed on merging. We’ll stop on the details a bit later.<\/p>\n\n\n\n

However, on December 17th, just before the report on the fourth quarter of 2020 was to be published, the quotations changed the direction and dropped by 9.01% to 31.51 USD. On the next day, when the quarterly report was presented to the public, the decline went on, and the price reached 27.1 USD per stock, which is a decline of 14%.<\/p>\n\n\n\n

<\/span>The main things from the report<\/span><\/h2>\n\n\n\n

The Canadian cannabis company managed to surprise both Wall-Street analysts and its own investors: the October-December statistics were beyond expectations. Let’s compare the results to those of Q4, 2019:<\/p>\n\n\n\n